ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Kansas » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in Kansas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JAMES NEEL MD

Cardiovascular Disease

14,291

$707K

787
608 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 21%

$49
Average prescription price

Avg: $49

LAYNE REUSSER M.D.

Cardiovascular Disease

13,173

$491K

1126
1034 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 21%

$37
Average prescription price

Avg: $49

THOMAS ASHCOM M.D., PH.D.

Cardiovascular Disease

12,933

$597K

901
824 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 21%

$46
Average prescription price

Avg: $49

RICHARD STECKLEY M.D.

Cardiovascular Disease

12,771

$571K

1032
958 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 21%

$45
Average prescription price

Avg: $49

GREGORY BOXBERGER MD

Cardiovascular Disease

11,540

$498K

898
818 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 21%

$43
Average prescription price

Avg: $49

JOSEPH GALICHIA MD

Cardiovascular Disease

10,045

$693K

875
729 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 21%

$69
Average prescription price

Avg: $49

ROGER EVANS M.D.

Cardiovascular Disease

9,954

$393K

1006
912 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 21%

$39
Average prescription price

Avg: $49

BASHAR MARJI M.D

Cardiovascular Disease

9,432

$496K

541
435 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 21%

$53
Average prescription price

Avg: $49

CHRISTINE FISHER MD, FACC

Cardiovascular Disease

8,982

$351K

942
852 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 21%

$39
Average prescription price

Avg: $49

HOSSEIN AMIRANI M.D.

Cardiovascular Disease

8,511

$309K

855
715 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 21%

$36
Average prescription price

Avg: $49

JASON TAUKE M.D.

Cardiovascular Disease

7,610

$652K

608
537 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 21%

$86
Average prescription price

Avg: $49

WASSIM SHAHEEN M.D.

Cardiovascular Disease

7,289

$362K

832
637 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

1%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 21%

$50
Average prescription price

Avg: $49

RAVI BAJAJ MD

Cardiovascular Disease

7,042

$284K

964
890 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 21%

$40
Average prescription price

Avg: $49

HUSSAM FARHOUD M.D.

Cardiovascular Disease

6,760

$254K

721
621 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 21%

$38
Average prescription price

Avg: $49

ROGER ROBERTS D.O.

Cardiovascular Disease

5,973

$306K

476
415 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 21%

$51
Average prescription price

Avg: $49

WILLIAM RITTER M.D.

Cardiovascular Disease

5,695

$309K

575
538 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 21%

$54
Average prescription price

Avg: $49

THOMAS DOYLE M.D.

Cardiovascular Disease

5,612

$180K

706
625 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 21%

$32
Average prescription price

Avg: $49

CHARLES BECK M.D.

Cardiovascular Disease

5,551

$214K

670
606 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 21%

$39
Average prescription price

Avg: $49

ELIZABETH DANG MD

Cardiovascular Disease

5,523

$307K

506
443 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 21%

$56
Average prescription price

Avg: $49

JAY JACKSON M.D.

Cardiovascular Disease

5,497

$251K

565
528 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 21%

$46
Average prescription price

Avg: $49

JHULAN MUKHARJI M.D.

Cardiovascular Disease

5,474

$276K

558
500 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 21%

$50
Average prescription price

Avg: $49

BRIAN BEARD M.D.

Cardiovascular Disease

5,442

$209K

576
483 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 21%

$38
Average prescription price

Avg: $49

DARRELL YOUNGMAN D.O.

Cardiovascular Disease

5,338

$368K

441
384 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 21%

$69
Average prescription price

Avg: $49

JAMES HURTIG MD

Cardiovascular Disease

5,330

$278K

565
468 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 21%

$52
Average prescription price

Avg: $49

CRAIG GERNON M.D.

Cardiovascular Disease

5,318

$187K

596
507 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 21%

$35
Average prescription price

Avg: $49

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank